Skip to main content

and
  1. No Access

    Article

    Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

    Various complications can influence hematopoietic cell transplantation (HCT) outcomes. Renal complications can occur during the early to late phases of HCT along with various factors. However, studies focusing...

    Ryu Yanagisawa, Hiroaki Koyama, Kimikazu Yakushi** in Bone Marrow Transplantation (2024)

  2. No Access

    Article

    Dexamethasone palmitate as an etoposide-free treatment for children with hemophagocytic lymphohistiocytosis after hematopoietic cell transplantation

    Rintaro Ono, Kenichi Sakamoto, Takehiko Doi, Ryu Yanagisawa in Bone Marrow Transplantation (2023)

  3. No Access

    Article

    Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors

    The incidence of severe adverse events (SAEs) and associated risk factors in hematopoietic cell transplantation donors needs to be clarified for related donors (relatives of the transplant recipient), whose cr...

    Ryu Yanagisawa, Tsuneaki Hirakawa, Noriko Doki in International Journal of Hematology (2023)

  4. No Access

    Article

    A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial

    Although clinical trials have reported an improvement in the prognosis of hemophagocytic lymphohistiocytosis (HLH), current treatment outcomes are unsatisfactory, especially in severe cases. Most clinical tria...

    Rintaro Ono, Kenichi Sakamoto, Takehiko Doi in International Journal of Hematology (2022)

  5. No Access

    Chapter

    Landscape for Regenerative Medicine Manufacturing in Japan

    In Japan, 6 years have passed since two important regenerative medicine laws came into force in November 2014 — the Act on the Safety of Regenerative Medicine and the Pharmaceuticals, Medical Devices, and Othe...

    Ryu Yanagisawa, Yozo Nakazawa in Cell Therapy (2022)

  6. Article

    Open Access

    Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome

    Genki Yamato, Takao Deguchi, Kiminori Terui, Tsutomu Toki, Tomoyuki Watanabe in Leukemia (2021)

  7. No Access

    Article

    Acquired dysfibrinogenemia: monoclonal λ-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation

    We report a case of acquired dysfibrinogenemia with monoclonal gammopathy of undetermined significance presenting λ-type IgA M protein. The patient showed lower functional (0.4 g/dL) and normal immunological fibr...

    Shinpei Arai, Tomu Kamijo, Yuka Takezawa in International Journal of Hematology (2020)

  8. No Access

    Article

    Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation

    Post-transplant early immune disorders and engraftment failure/delay are major issues in unrelated umbilical cord blood transplantation (UCBT). We evaluated graft-versus-host disease (GVHD) prophylaxis approac...

    Tomonari Shigemura, Kazuo Sakashita, Eri Okura in International Journal of Hematology (2020)

  9. Article

    Correction to: Factors predicting the recurrence of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol

    The correct name of the first author should be ‘‘Ryu Yanagisawa’’, and not ‘‘Ryu Yanagaisawa’’ as given in the original publication of the article.

    Ryu Yanagisawa, Kazuyuki Matsuda, Shouichi Ohga in International Journal of Hematology (2019)

  10. No Access

    Article

    Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan

    Recent advances in intensive chemo- and immunotherapy have contributed to the outcome of hemophagocytic lymphohistiocytosis (HLH); however, the prognosis of HLH in children differs by HLH subtype. In Japan, se...

    Ryu Yanagisawa, Yozo Nakazawa, Kazuyuki Matsuda in International Journal of Hematology (2019)

  11. No Access

    Article

    Neuroblastoma invading the kidney through the renal hilum

    Ryu Yanagisawa, Yoshifumi Ogiso, Tomoko Furukawa in Clinical and Experimental Nephrology (2018)

  12. No Access

    Article

    The role of evaluation in achieving the SDGs

    This paper proposes a framework on Sustainable Development Goal (SDG) evaluation, arguing that attainment of the 17 goals and 169 related targets depends significantly on practice-based monitoring and evaluati...

    Aki Yonehara, Osamu Saito, Kaoru Hayashi, Masafumi Nagao in Sustainability Science (2017)

  13. Article

    Open Access

    Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity

    Active human dendritic cells (DCs), which efficiently induce immune responses through their functions as antigen-presenting cells, exhibit direct anti-tumour killing activity in response to some pathogens and ...

    Terutsugu Koya, Ryu Yanagisawa, Yumiko Higuchi, Kenji Sano in Scientific Reports (2017)

  14. No Access

    Article

    Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review

    An 8-year-old boy with a bone marrow relapse of T cell acute lymphoblastic leukemia underwent stem-cell transplantation from a human leukocyte antigen (HLA)-haploidentical mother. Five months later, he relapse...

    Ryu Yanagisawa, Yozo Nakazawa, Kazuo Sakashita in International Journal of Hematology (2016)

  15. Article

    Open Access

    Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies

    Conventional myeloablative conditioning (MAC) regimens often cause severe regimen-related toxicity (RRT). Furthermore, many patients suffer from poor quality of life in accordance with the increase in long-ter...

    Koichi Hirabayashi, Yozo Nakazawa, Kazuo Sakashita, Takashi Kurata in Scientific Reports (2014)

  16. No Access

    Article

    Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies

    Long-term surviving recipients of allogeneic hematopoietic stem cell transplantation (HSCT) often suffer from diabetes mellitus (DM). We sought to identify risk factors for the development of post-transplant ...

    Kanae Hirabayashi, Yozo Nakazawa, Hiroki Matsuura in International Journal of Hematology (2014)

  17. No Access

    Article

    Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children

    Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome and has a varied genetic background. The polymorphism of interferon regulatory factor 5 gene (IRF5) was reported to be associated with susc...

    Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae in Journal of Clinical Immunology (2011)

  18. No Access

    Article

    Successful Unrelated Cord Blood Transplantation Using a Reduced-Intensity Conditioning Regimen in a 6-Month-Old Infant with Congenital Neutropenia Complicated by Severe Pneumonia

    Here we report the first successful unrelated cord blood transplantation (CBT) using reduced-intensity conditioning for the treatment of congenital neutropenia in a 6-month-old infant with complications of sev...

    Yozo Nakazawa, Kazuo Sakashita, Mizuho Kinoshita in International Journal of Hematology (2004)